HealthLynked Corp. Files 8-K with Corporate Updates
Ticker: HLYK · Form: 8-K · Filed: Sep 5, 2025 · CIK: 1680139
| Field | Detail |
|---|---|
| Company | Healthlynked Corp (HLYK) |
| Form Type | 8-K |
| Filed Date | Sep 5, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, disclosure
TL;DR
HealthLynked Corp. filed an 8-K on Sept 2, 2025, with corporate changes and disclosures. Watch for impacts on security holder rights.
AI Summary
HealthLynked Corp. filed an 8-K on September 5, 2025, reporting events that occurred on September 2, 2025. The filing indicates material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This 8-K filing signals significant changes in HealthLynked Corp.'s corporate structure or security holder rights, which could impact investors' understanding of their stake in the company.
Risk Assessment
Risk Level: medium — Filings detailing modifications to security holder rights or amendments to corporate bylaws can introduce uncertainty and potential risks for investors.
Key Numbers
- 000-55768 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-1634127 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- HealthLynked Corp. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- Naples, FL (location) — Principal executive offices
FAQ
What specific material modifications were made to the rights of HealthLynked Corp. security holders?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item information, but the specific details of these modifications are not provided in the excerpt.
What amendments were made to HealthLynked Corp.'s articles of incorporation or bylaws?
The filing lists 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item information, but the specific amendments are not detailed in the provided text.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, preventing selective disclosure.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on September 2, 2025.
What is HealthLynked Corp.'s principal executive office address?
HealthLynked Corp.'s principal executive office is located at 1265 Creekside Parkway, Suite 302, Naples, FL 34108.
Filing Stats: 1,117 words · 4 min read · ~4 pages · Grade level 9.8 · Accepted 2025-09-05 09:00:28
Key Financial Figures
- $0.0001 — nding shares of common stock, par value $0.0001 per share (the " Common Stock "), at a
Filing Documents
- ea0256100-8k_health.htm (8-K) — 29KB
- ea025610001ex3-1_health.htm (EX-3.1) — 6KB
- ea025610001ex99-1_health.htm (EX-99.1) — 10KB
- ex3-1_001.jpg (GRAPHIC) — 986KB
- ex3-1_002.jpg (GRAPHIC) — 737KB
- ex3-1_003.jpg (GRAPHIC) — 439KB
- 0001213900-25-084743.txt ( ) — 3187KB
- hlyk-20250902.xsd (EX-101.SCH) — 3KB
- hlyk-20250902_lab.xml (EX-101.LAB) — 33KB
- hlyk-20250902_pre.xml (EX-101.PRE) — 22KB
- ea0256100-8k_health_htm.xml (XML) — 3KB
03. Material Modification to Rights
Item 3.03. Material Modification to Rights of Security Holders. To the extent required by
03 of Form 8-K, the information contained in Item 5.03 of this report is incorporated herein by reference
Item 3.03 of Form 8-K, the information contained in Item 5.03 of this report is incorporated herein by reference.
03. Amendment to Articles of Incorporation or Bylaws; Change
Item 5.03. Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year. The board of directors and stockholders of HealthLynked Corp., a Nevada corporation (the " Company "), has approved a reverse stock split of the Company's issued and outstanding shares of common stock, par value $0.0001 per share (the " Common Stock "), at a ratio of 1-for-100 (the " Reverse Stock Split "). The Reverse Stock Split went effective on September 4, 2025 (the " Market Effective Date "). Effects of the Reverse Stock Split Effective Date; Symbol; CUSIP Number . The Common Stock began trading on a split-adjusted basis on the OTCQB on the Market Effective Date. In connection with the Reverse Stock Split, the CUSIP number for the Common Stock changed to 42228P 300. The Company's ticker symbol on the OTCQB will be "HLYKD" for 20 trading days, including the Market Effective Date. Split Adjustment; Treatment of Fractional Shares . The total number of shares of Common Stock held by each stockholder of the Company was converted automatically into the number of shares of Common Stock equal to: (i) the number of issued and outstanding shares of Common Stock held by each such stockholder immediately prior to the Reverse Stock Split divided by (ii) 100. Any fractional share of Common Stock that would otherwise result from the Reverse Stock Split is being rounded to a whole share and, as such, any stockholder who otherwise would have held a fractional share after giving effect to the Reverse Stock Split instead holds one whole share of the post-Reverse Stock Split Common Stock after giving effect to the Reverse Stock Split. As a result, no fractional shares are being issued in connection with the Reverse Stock Split and no cash or other consideration is being paid in connection with any fractional shares that would otherwise have resulted from the Reverse Stock Split. The Company is treating stockholders holding shares of Common Stock in "street name" (that is, held through a bank
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 4, 2025, the Company issued a press release announcing the Reverse Stock Split. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01. The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the Company under the Securities Act of 1933, as amended.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment to Amended and Restated Articles of Incorporation of HealthLynked Corp. 99.1 Press Release dated September 4, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHLYNKED CORP. Date: September 5, 2025 /s/ Jeremy Daniel Jeremy Daniel Chief Financial Officer 2